• Kevin P Jackson, Svein Faerestrand, Francois Philippon, Raymond Yee, Melissa H Kong, Axel Kloppe, Maria Grazia Bongiorni, Scott F Lee, Robert C Canby, Erika Pouliot, Mireille M E van Ginneken, and George H Crossley.
• Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
• J. Cardiovasc. Electrophysiol. 2020 May 1; 31 (5): 1147-1154.

IntroductionThe Medtronic Attain Stability Quad lead is a quadripolar left ventricular (LV) lead with an active fixation helix assembly designed to fixate the lead within the coronary sinus and pace nonapical regions of the LV. The primary objective of this study was to determine the safety and effectiveness of this novel active fixation quadripolar LV lead.MethodsPatients with standard indications for cardiac resynchronization therapy (CRT) were enrolled. All patients were followed at 3 and 6 months post-implant and every 6 months thereafter until study closure. Pacing capture thresholds (PCTs) were measured at implant and each follow-up and adverse events (AEs) were recorded upon occurrence.ResultsOf the 440 patients who underwent implant procedures, placement of the Attain Stability Quad lead was successful in 426 (96.8%). LV lead-related complications occurred in 10 patients (2.3%), including LV lead dislodgement in three patients (0.7%). The percentage of patients with at least one LV pacing vector with a PCT ≤2.5 V at a 6-month follow-up was 96.3%. The LV lead was successfully fixated to the prespecified pacing location in 97.4% of cases.ConclusionsThis large, multinational study of the Attain Stability Quad lead demonstrated a high rate of implant success with a low complication rate. The active fixation mechanism allowed precise placement of the pacing electrodes at the desired target region with good PCTs and a very low dislodgement rate.© 2020 Wiley Periodicals, Inc.

23 keywords...

hide…